Innovex [INVX] vs Baker Hughes Company [BKR] Detailed Stock Comparison
Innovex
NYSE
Loading...
Baker Hughes Company
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Innovex wins in 11 metrics, Baker Hughes Company wins in 7 metrics, with 0 ties. Innovex appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Innovex | Baker Hughes Company | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 8.20 | 14.63 | Innovex |
| Price-to-Book Ratio | 1.19 | 2.49 | Innovex |
| Debt-to-Equity Ratio | 9.91 | 33.77 | Innovex |
| PEG Ratio | -0.10 | 0.65 | Innovex |
| EV/EBITDA | 8.22 | 10.11 | Innovex |
| Profit Margin (TTM) | 16.66% | 11.04% | Innovex |
| Operating Margin (TTM) | 12.45% | 12.84% | Baker Hughes Company |
| EBITDA Margin (TTM) | 12.45% | 12.84% | Baker Hughes Company |
| Return on Equity | 21.44% | 18.36% | Innovex |
| Return on Assets (TTM) | 7.25% | 5.85% | Innovex |
| Free Cash Flow (TTM) | $79.85M | $2.05B | Baker Hughes Company |
| Dividend Yield | N/A | 2.41% | N/A |
| 1-Year Return | 9.16% | 27.09% | Baker Hughes Company |
| Price-to-Sales Ratio (TTM) | 1.37 | 1.60 | Innovex |
| Enterprise Value | $1.22B | $47.25B | Baker Hughes Company |
| EV/Revenue Ratio | 1.41 | 1.71 | Innovex |
| Gross Profit Margin (TTM) | 31.98% | 23.37% | Innovex |
| Revenue per Share (TTM) | $13 | $28 | Baker Hughes Company |
| Earnings per Share (Diluted) | $2.10 | $3.06 | Baker Hughes Company |
| Beta (Stock Volatility) | N/A | 0.92 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Innovex vs Baker Hughes Company Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Innovex | -2.59% | 7.61% | 11.40% | 23.58% | 5.01% | 20.25% |
| Baker Hughes Company | -0.74% | 4.58% | 11.84% | 22.33% | 0.31% | 7.70% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Innovex | 9.16% | -26.33% | -48.79% | -74.26% | -67.66% | -11.04% |
| Baker Hughes Company | 27.09% | 71.30% | 202.43% | -18.20% | 15.60% | -19.41% |
Performance & Financial Health Analysis: Innovex vs Baker Hughes Company
| Metric | INVX | BKR |
|---|---|---|
| Market Information | ||
| Market Cap | $1.18B | $44.13B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 324,722 | 4,866,910 |
| 90 Day Avg. Volume | 371,197 | 7,381,997 |
| Last Close | $16.95 | $44.43 |
| 52 Week Range | $11.93 - $19.42 | $32.25 - $49.40 |
| % from 52W High | -12.72% | -10.06% |
| All-Time High | $121.07 (Oct 21, 2013) | $100.29 (Oct 15, 2007) |
| % from All-Time High | -86.00% | -55.70% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.72% | -0.03% |
| Quarterly Earnings Growth | 0.61% | 0.21% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.11% |
| Operating Margin (TTM) | 0.12% | 0.13% |
| Return on Equity (TTM) | 0.21% | 0.18% |
| Debt to Equity (MRQ) | 9.91 | 33.77 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.48 | $17.96 |
| Cash per Share (MRQ) | $1.10 | $3.13 |
| Operating Cash Flow (TTM) | $148.37M | $3.42B |
| Levered Free Cash Flow (TTM) | $-139,353,120 | $1.10B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.41% |
| Last 12-Month Dividend | N/A | $1.11 |
Valuation & Enterprise Metrics Analysis: Innovex vs Baker Hughes Company
| Metric | INVX | BKR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 8.20 | 14.63 |
| Forward P/E | 22.35 | 17.42 |
| PEG Ratio | -0.10 | 0.65 |
| Price to Sales (TTM) | 1.37 | 1.60 |
| Price to Book (MRQ) | 1.19 | 2.49 |
| Market Capitalization | ||
| Market Capitalization | $1.18B | $44.13B |
| Enterprise Value | $1.22B | $47.25B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.41 | 1.71 |
| Enterprise to EBITDA | 8.22 | 10.11 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.92 |
| Book Value per Share (MRQ) | $14.48 | $17.96 |
Financial Statements Comparison: Innovex vs Baker Hughes Company
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INVX | BKR |
|---|---|---|
| Revenue/Sales | $240.42M | $6.43B |
| Cost of Goods Sold | $163.91M | $4.95B |
| Gross Profit | $76.50M | $1.48B |
| Research & Development | N/A | $146.00M |
| Operating Income (EBIT) | $29.21M | $752.00M |
| EBITDA | $47.30M | $897.00M |
| Pre-Tax Income | $21.36M | $561.00M |
| Income Tax | $6.61M | $152.00M |
| Net Income (Profit) | $14.76M | $409.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INVX | BKR |
|---|---|---|
| Cash & Equivalents | $68.12M | $3.28B |
| Total Current Assets | $632.64M | $16.84B |
| Total Current Liabilities | $145.82M | $12.59B |
| Long-Term Debt | $65.64M | $5.97B |
| Total Shareholders Equity | $978.38M | $17.21B |
| Retained Earnings | $225.38M | $-5.44B |
| Property, Plant & Equipment | $78.27M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INVX | BKR |
|---|---|---|
| Operating Cash Flow | $49.08M | $569.00M |
| Capital Expenditures | $1.00M | N/A |
| Free Cash Flow | $24.03M | $409.00M |
| Debt Repayment | $-91.91M | N/A |
| Common Stock Repurchase | $-626,000 | $-188.00M |
Short Interest & Institutional Ownership Analysis
| Metric | INVX | BKR |
|---|---|---|
| Shares Short | 2.97M | 24.73M |
| Short Ratio | 7.50 | 2.86 |
| Short % of Float | 0.08% | 0.03% |
| Average Daily Volume (10 Day) | 324,722 | 4,866,910 |
| Average Daily Volume (90 Day) | 371,197 | 7,381,997 |
| Shares Outstanding | 69.18M | 989.53M |
| Float Shares | 37.89M | 983.58M |
| % Held by Insiders | 0.03% | 0.00% |
| % Held by Institutions | 1.05% | 1.01% |
Dividend Analysis & Yield Comparison: Innovex vs Baker Hughes Company
| Metric | INVX | BKR |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.11 |
| Last 12-Month Dividend Yield | N/A | 2.41% |
| 3-Year Avg Annual Dividend | N/A | $0.89 |
| 3-Year Avg Dividend Yield | N/A | 0.60% |
| 3-Year Total Dividends | N/A | $2.68 |
| Ex-Dividend Date | N/A | Aug 05, 2025 |